Regulatory Approaches to Electronic Labelling in the USA, EU, and India: A Comparative Overview
Komal Saini1, Ramandeep Singh2
1Chandigarh College of Pharmacy, Chandigarh Group of Colleges, Landran, Mohali, Punjab, 140307, India. komalsainiks@gmail.com.
Objective:
In this era of growth, e-labelling is becoming increasingly important as the labels are important sources of information for patients. However, regulations governing e-labeling for pharmaceuticals and medical equipment varies throughout the countries. This review compares the e-labelling regulation approaches in EU, USA, and India.
Scope:
The regulations have been initiated by appropriate governments and/or health authorities of EU, USA, and India in collaboration with key stakeholders, including patients, healthcare providers, pharmaceutical companies, environmental and regulatory agencies. EU and USA have established the digital labelling but India still relies on paper instruction manuals with limited digital systems.
Methodology:
The regulatory information and current trends of e-labelling in EU, US, and India were studied and compared for electronic prescribing and electronic decision support systems with health record. Regulatory information was recognized through a structured review of official regulatory agency websites (FDA, EMA, CDSCO), international organizations (WHO, ICH), and peer-reviewed literature accessed through databases such as PubMed and Google Scholar. Eligible sources comprised official regulations, guidance documents, policy reports, and peer-reviewed articles specifically addressing pharmaceutical e-labelling, while draft policies and unrelated documents were excluded. Data were synthesized using qualitative thematic analysis, and cross-jurisdictional comparisons were structured across predefined domains including regulatory scope, legal status, implementation stage, digital infrastructure, and stakeholder accessibility.
Key Findings:
Common challenges include maintaining authenticity, readability, and interoperability of e-labels. Technologies like QR codes, barcoding, and decision support tools increase safety and access. However, digital implementation and regulatory maturity differ generally between the developed and developing nations.
More Related Videos
09:30Author Spotlight: Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
09:51TD-DFT Guided Advanced E-Eye Sensing Technique for On-site Quantification of Fe, Cr, F, and As in the Environmental, Biological, and Food Samples
Published on: September 19, 2025
Related Concept Videos
Drug Regulation
Global Regulatory Systems
Drug Control Governance: Regulatory Bodies and Their Impact
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Labeling Emotion
Drug Nomenclature
